human clinical trials bpc-157 bpc 157 trial dose microgram vs TB-500: Complete Comparison (2026) BPC-157 Cost: What You Need bpc-157 human clinical trials evidence

Choose your IV and start experiencing the benefits

Evidence remains largely preclinical, but findings indicate possible benefits in reducing inflammation and aiding recovery in digestive tissues, especially in conditions involving ulcers or irritation

Smaller volumes give higher mg-per-IU and faster draws

Based on the phase 2 and phase 3 trial protocols: Weeks 1-4: 1 mg once weekly Weeks 5-8: 2 mg once weekly Weeks 9-12: 4 mg once weekly Weeks 13-16: 8 mg once weekly Weeks 17 onward: 12 mg once weekly (maximum dose) The starting dose of retatrutide is deliberately low because the triple-agonist mechanism produces more intense initial side effects than single-pathway compounds